NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/30/2024
Back to search
Official data from USPTO
BEIHAI BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BEIHAI BIOTECH
ST13
US500000098064039Class
5
Filing
98064039
Registration
7460766
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
07/30/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/29/2023
Registration date
07/30/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/30/2024
Last transaction
07/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Zhuhai, Guangdong, CN
Examiner
LEE, DOUGLAS
Law office
O20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Zhuhai Beihai Biotech Co., Ltd.
Representatives
Charles Ho Barron & Young PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for human purposes for the treatment of cancer; Pharmaceutical preparations for the treatment of infectious diseases and for use in oncology; Chemico-pharmaceutical preparations for pharmaceutical or medical purposesfor the treatment of cancer; Drugs for medical purposes in the nature of pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical purposes for the treatment of cancer; Chemical preparations for medical purposes for the treatment of cancer; Biological preparations for medical purposes for the treatment of cancer; Biochemical medicines for the treatment of cancer; Medicines made of Chinese traditional medicinal herbs; Blood plasma
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2024
PUBO
PUBLISHED FOR OPPOSITION
05/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/27/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/18/2024
GNRT
NON-FINAL ACTION E-MAILED
03/18/2024
CNRT
NON-FINAL ACTION WRITTEN
03/18/2024
DOCK
ASSIGNED TO EXAMINER
03/14/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/31/2023
NWAP
NEW APPLICATION ENTERED
07/03/2023
Continuous trademark protection
Get notified about every new filing that threatens BEIHAI BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.